Moxonidine Catalog No.:M9133-10 In the cathepsin L inhibition

In the cathepsin L inhibition assay

KAN0438757 is a potent and selective inhibitor of the metabolic kinase PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2

Smiles: [2H]C([2H])([2H])OC1=C(C/C=C(\C)/CCC(O)=O)C(O)=C2C(COC2=O)=C1C

1-3H3/b9-5+

InChiKey: URZFPFDMMGLCJC-AFGPOOCPSA-N

Moxonidine Catalog No.:M9133-10 In the cathepsin L inhibitionMoxonidine is a centrally acting antihypertensive drug that is selective agonist at the imidazoline receptor subtype 1 (I1). This receptor subtype is found in both the rostral ventro lateral pressor and ventromedial depressor areas of the medulla oblongata. Moxonidine therefore causes a decrease in sympathetic nervous system activity and a decrease in blood pressure. Moxonidine may also promote sodium excretion, improve insulin resistance and glucose